Anal Dysplasia: Symptoms, HPV Risk, Screening and Treatment
Table of Contents
Key takeaways
- Anal dysplasia means abnormal cell changes in the lining of the anal canal; it is often linked with persistent high-risk HPV infection.
- Many people have no symptoms, so higher-risk groups may be offered specialist assessment or surveillance.
- Symptoms that need assessment include anal bleeding, pain, itching, discharge, a lump, ulceration or a change in bowel habit.
- Diagnosis may involve examination, anal cytology, high-resolution anoscopy and biopsy.
- HPV vaccination, condoms, smoking cessation, HIV care and follow-up can reduce risk, but they do not replace medical assessment.
Overview
Anal dysplasia is abnormal change in the squamous cells lining the anal canal. It is not the same as anal cancer, but higher-grade changes can be a precursor to cancer in some people. The condition is often described using terms such as anal intraepithelial neoplasia, low-grade squamous intraepithelial lesion or high-grade squamous intraepithelial lesion.
The main driver is persistent infection with high-risk human papillomavirus. HPV is common and often clears without causing serious disease. Dysplasia becomes more concerning when high-risk HPV persists, especially in people with immune suppression. The aim of assessment is to identify clinically important changes early and decide whether monitoring or treatment is appropriate.
Anal symptoms can feel embarrassing to discuss, but clinicians are used to assessing them. Bleeding or pain should not be assumed to be piles, particularly if symptoms are persistent, recurrent or associated with a lump or discharge.
Types and grading
Low-grade changes usually reflect HPV-related cell changes with lower immediate cancer risk. They may be monitored, especially if symptoms are mild and there is no high-grade lesion on biopsy.
High-grade changes are more clinically significant because they are closer to the pathway that can lead to anal cancer. High-grade lesions may be treated or closely monitored depending on immune status, lesion size, symptoms, local expertise and patient preference.
Grading can be confusing because terminology has changed over time. What matters is the biopsy result, whether high-risk HPV is present, whether the immune system is suppressed, and whether there is any sign of invasive cancer.
Symptoms
Many people with anal dysplasia have no symptoms. When symptoms occur, they can include anal bleeding, itching, pain, discomfort during bowel movements, mucus or discharge, a lump, ulcer, wart-like change or a feeling of fullness. These symptoms can also be caused by haemorrhoids, fissures, eczema, sexually transmitted infections, inflammatory bowel disease or cancer, so examination is important.
Symptoms after receptive anal sex, new partners or an STI diagnosis should prompt sexual health review. Women with a history of cervical, vulval or vaginal high-grade HPV-related disease may also need tailored advice because HPV-related disease can affect more than one lower genital tract site.
Causes and risk factors
Persistent high-risk HPV infection is the central risk factor. HPV can spread through genital, anal and oral sexual contact, including skin-to-skin contact. Condoms reduce risk but do not remove it completely because HPV can affect uncovered skin.
Risk is higher in people living with HIV, people taking long-term immune-suppressing medicines, transplant recipients, men who have sex with men, people with a history of receptive anal sex, smokers, and people with previous HPV-related cervical, vulval, vaginal or penile disease. Smoking may impair local immune response and is linked with persistence of HPV-related cell changes.
Diagnosis and screening
Assessment may include a history, visual inspection, digital rectal examination and anoscopy. Anal cytology is sometimes used to collect cells, similar in principle to cervical screening, but anal screening pathways vary and are not universal. High-resolution anoscopy allows the clinician to inspect the anal canal under magnification and take targeted biopsies.
Biopsy is the test that confirms the grade of dysplasia. If a lesion looks suspicious for cancer, biopsy and urgent specialist referral are important. People living with HIV or significant immune suppression may be managed in specialist clinics because recurrence and persistence are more common.
A good examination should be consent-led and explained before it happens. You can ask for a chaperone, ask the clinician to pause, and discuss pain control if examination is uncomfortable. This is particularly important for people with previous trauma, pelvic floor pain, vaginismus, inflammatory bowel disease or recent anal injury.
Treatment and follow-up
Treatment depends on grade, symptoms, immune status and local expertise. Low-grade changes may be monitored. High-grade lesions may be treated with ablative therapy, excision or topical prescription treatments in selected cases. Treatment can reduce the burden of abnormal cells, but recurrence can happen, so follow-up is important.
Supportive care can help symptoms but does not treat dysplasia itself. Warm water sitz baths, avoiding perfumed products, treating constipation and using medicines prescribed for pain or irritation may help comfort while awaiting assessment. Do not apply over-the-counter wart or acid treatments inside the anus unless a clinician specifically advises it.
Follow-up intervals are personalised. A specialist may consider the original grade, margin status after treatment, immune status, smoking, HIV viral control and whether new lesions appear. Missing follow-up can allow high-grade changes to persist unnoticed, while over-treatment can cause pain or scarring, so the plan should be clear and realistic.
Prevention and sexual health
HPV vaccination reduces risk from the HPV types included in the vaccine and is most effective before exposure, but it can still be relevant for some adults depending on eligibility and clinical advice. Condoms and barriers for oral-anal contact reduce exposure to HPV and other infections. Stopping smoking, maintaining HIV viral suppression where relevant and attending follow-up all support risk reduction.
Partners may also need STI testing depending on symptoms and exposure. A sexual health clinic can give confidential advice about HPV, HIV testing, PrEP, vaccines, safer sex and symptoms without judgement.
Anal dysplasia is not a marker of poor hygiene or personal failure. HPV is common, and stigma can delay care. The useful focus is practical: vaccination where appropriate, barrier use, prompt assessment of symptoms and keeping planned surveillance appointments.
When to seek medical advice
Book medical or sexual health review for anal bleeding, pain, itching, discharge, a lump, ulcer, wart-like growth, persistent change in bowel habit or symptoms after sexual exposure. Seek prompt review if you live with HIV, take immune-suppressing medicines or have a history of HPV-related high-grade disease.
Use NHS 111 for urgent advice if bleeding is heavy, pain is severe, fever develops, or you feel very unwell. Call 999 for severe bleeding with faintness, collapse or signs of sepsis.
Sources
- NHS: Anal cancer: https://www.nhs.uk/conditions/anal-cancer/
Relevance: Supports UK-facing information on symptoms and the need for assessment of anal cancer warning signs. - NHS: HPV vaccine overview: https://www.nhs.uk/conditions/vaccinations/hpv-human-papillomavirus-vaccine/
Relevance: Supports prevention discussion around HPV vaccination. - National Cancer Institute: Anal cancer prevention: https://www.cancer.gov/types/anal/hp/anal-prevention-pdq
Relevance: Provides evidence-based detail on HPV, risk factors and prevention of anal cancer pathways. - PubMed Central: Anal intraepithelial neoplasia review: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479653/
Relevance: Supports clinical discussion of anal dysplasia terminology, diagnosis and management.
Disclaimer
Educational only. Results vary. Not a cure.
Details that must be confirmed before publishing: confirm whether WHM wants a dedicated HPV and anal screening explainer linked from this article.
